We use cookies to improve our website and your experience when using it. To find out more about the cookies we use and how to delete them, see our Privacy Policy



 SelectNAplus Instrument Benefits:
  • Innovative walk-away pathogen DNA extraction
  • Human-DNA-removal technology (MolYsis™)
  • Validated for primary sterile body fluids and tissues
  • DNA-free consumables and reagents
  • Bench-top instrument
  • Flexible:  1 to 12 samples
  • Superior diagnostic performance
  • Suitable for Next Generation Sequencing

The complete solution for broad-range pathogen diagnosis

Molzym’s MolYsis™ technology is an approach for selective lysis of human cells and degradation of released human DNA followed by isolation of purified microbial DNA. In a long list of publications, MolYsis™ has been documented to be a powerful tool of providing minute amounts of microbial DNA from a wide variety of clinical material to ultra-sensitive molecular testing.  

Now, Molzym for the first time has developed a fully automated, walk-away system, SelectNA™plus, that proceeds clinical material through the MolYsis™ method. The kit MolYsis-SelectNA™plus allows the extraction of DNA from enriched microbes from whole blood and other body fluids, tissues and swabs. For the automatic extraction and Real-Time PCR diagnosis of pathogen DNA a kit, Micro-Dx™ CE IVD, is provided.

SelectNA™plus is the instrumental component of the complete system, Micro-Dx™ CE IVD. The instrument is used for the fully automated extraction and purification of pathogen DNA from whole blood and other primary body fluids, swabs and tissue samples based on the MolYsis™ technology. SelectNA™plus considerably saves hands-on time in the most laborious part, DNA isolation, and at the same time decreases errors by handling. The highly contained automat avoids air-borne and cross contamination during pre-analysis and thus reduces false-positive results in PCR or Real-Time PCR analyses.


Request Product Information
Request Product Quote

Molzym Blog
This email address is being protected from spambots. You need JavaScript enabled to view it.